ClinicalTrials HQ

Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss

Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss

Active, not recruiting · NCT07446998 · Registry updated 2026-09-04
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight LossBody Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutritionActive, not recruitingPhase 22026-09-04NCT07446998

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Veru Inc.1

13 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
ALSA ResearchNew YorkUnited States1
Centennial Medical Group (CMG)ColumbiaUnited States1
Coastal Research Institute, LLCFayettevilleUnited States5
DM Clinical - DallasIrvingUnited States1
DM Clinical - SeattleSeattleUnited States1
DM Clinical Research - MIADoralUnited States1
DM Clinical Research - PhoenixPhoenixUnited States2
IMIC Research a Rovia Clinical Research CompanyMiamiUnited States1
Paramo HealthMiamiUnited States1
Paramo HealthMiamiUnited States1
Pennington Biomedical Research CenterBaton RougeUnited States43
Sky Integrative Medical CenterRidgelandUnited States5
Universal Axon Clinical Research (Rovia - UACR)DoralUnited States1